HCV–HIV coinfected pregnant women: data from a multicentre study in Italy

Infection

Volumn 44, Issue 2, 2016, Pages 235-242

  Baroncelli, S ^a   Pirillo, M F ^a   Amici, R ^a   Tamburrini, E ^b   Genovese, O ^b   Ravizza, M ^c   Maccabruni, A ^d   Masuelli, G ^e   Guaraldi, G ^f   Liuzzi, G ^g   Pinnetti, C ^g   Giacomet, V ^h   Degli Antoni, A ⁱ   Vimercati, A ^j   Dalzero, S ^c   Sacchi, V ^c   Floridia, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PARMA   (Italy)

^j UNIVERSITY OF BARI   (Italy)

more..

Author keywords

HCV; HCV transmission; HCV RNA; HIV; HIV RNA; Pregnancy; Preterm delivery

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; HEPATITIS C VIRUS RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CONGENITAL MALFORMATION; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MIXED INFECTION; OBSERVATIONAL STUDY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; VIRUS LOAD; VIRUS TRANSMISSION; BLOOD; CLINICAL TRIAL; COINFECTION; COMPLICATION; HEPACIVIRUS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MALE; MULTICENTER STUDY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURITY; UNIVERSITY HOSPITAL;

ADULT; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INFANT, NEWBORN; ITALY; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; RNA, VIRAL; VIRAL LOAD;

EID: 84945299743     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0852-0     Document Type: Article

References (32)

1. Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356:904–7.
2. Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis. 2003;187:345–51.
3. Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal. 2005;90:F156–60.
4. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology. 2002;36:S106–13.
5. European Paediatric Hepatitis. C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission ofhepatitis C virus infection. J Infect Dis. 2005;192:1872–9.
6. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCVinfection acquired in infancy. J Infect Dis. 2005;192:1880–9.
7. Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses. 2012;4:3531–50.
8. Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. Am J Perinatol. 2013;30:149–59.
9. Tosone G, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Orlando R. Vertical hepatitis C virus transmission: main questions and answers. World J Hepatol. 2014;6:538–48.
10. Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014. doi:10.1038/jp.2014.167(epub ahead of print).
11. Dal Molin G, D’Agaro P, Ansaldi F, et al. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol. 2002;67:137–42.
12. Ruiz-Extremera A, Muñoz-Gámez JA, Salmerón-Ruiz MA, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology. 2011;53:1830–8.
13. Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis. 2007;44:1123–31.
14. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCVTransmission. Lancet. 1995;345:289–91.
15. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J. 1995;14:195–9.
16. Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis. 1997;25:1121–4.
17. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32:33–46.
18. Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect. 2006;134:1120–7.
19. Girardi E, Vanacore P, Costa F, Solmone M, Angeletti C, Capobianchi MR, et al. Trends in HIV prevalence among pregnant women in Italy, 1994–2002. J Acquir Immune Defic Syndr. 2006;41:361–4.
20. Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf. 2002;11:465–75.
21. Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353–61.
22. AIDS Clinical Trials Group (ACTG). Division of AIDS Table For Grading The Severity of Adult and Pediatric Adverse Events Version 1.0, Division of AIDS, National Institute of Allergy and Infectious Diseases. December 2004; Clarification August 2009.
23. Snijdewind IJ, Smit C, Godfried MH, Nellen JF, de Wolf F, Boer K, van der Ende ME. HCV coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy. J Infect. 2012;64:409–16.
24. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36:S65–73.
25. Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Muggiasca ML, Guaraldi G, et al. Declining HCV seroprevalence in pregnant women with HIV. Epidemiol Infect. 2010;138:1317–21.
26. Basso M, Franzetti M, Scaggiante R, et al. HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV–HCV co-infected patients: a 3-years follow-up study. AIDS Res Ther. 2014;11:21.
27. Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54:1348–60.
28. Watts DH, Williams PL, Kacanek D, et al. Combination antiretroviral use and preterm birth. J Infect Dis. 2013;207:612–21.
29. Short CE, Taylor GP. Antiretroviral therapy and preterm birth in HIV-infected women. Expert Rev Anti Infect Ther. 2014;12:293–306.
30. Ravizza M, Martinelli P, Bucceri A, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis. 2007;195:913–4.
31. Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010;30:765–70.
32. Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011;31:1163–70.